Alnylam Pharmaceuticals reported $110.95M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amgen AMGN:US $ 4152M 37M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bluebird Bio BLUE:US $ 0.77M 12.74M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Takeda 4502:JP Y 783476M 4328M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
YTE INCY:US $ 21.3M 4.63M